Abstract
It has been previously showed that fructose-1,6-bisphosphate (FBP) has anti-inflammatory and immunomodulatory effects on several experimental inflammation models. However, the effects and mechanism of FBP on Zymosan-induced acute lung injury (ALI) in mice had not been tested. In this study, our aim was to assess the anti-inflammatory activities of FBP on Zymosan-induced ALI. We found that in vivo treatment with FBP (500 mg/kg i.p.) markedly decreased the nitric oxide (NO) levels in the lungs and significantly reduced bronchoalveolar lavage fluid total cell and neutrophil counts and protein exudation after Zymosan challenge. Furthermore, FBP inhibited inducible nitric oxide synthase (iNOS) activities in RAW macrophages. Meanwhile, FBP did not inhibit the cyclooxigenase 2, interleukin-6, and nuclear factor kappa B transcription. Taken together, these results suggest that FBP shows anti-inflammatory effects through inhibiting lung edema, NO, and iNOS activities.
References
Apr 1, 1989·Cell Biochemistry and Function·L GalzignaR Scuri
Nov 1, 1994·Journal of Leukocyte Biology·Q Xie, C Nathan
Sep 13, 1996·The Journal of Biological Chemistry·J RuanC Nathan
Mar 17, 1998·Biochemical and Biophysical Research Communications·L EddeM P Sherman
Jan 16, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Fernanda B NunesJarbas R De Oliveira
Mar 29, 2003·American Journal of Respiratory and Critical Care Medicine·Michael A MatthayAndrea L Harabin
Apr 17, 2003·Toxicology Letters·Fernanda Bordignon NunesJarbas Rodrigues De Oliveira
Sep 30, 2003·Diabetes·Shinsuke KiritoshiEiichi Araki
Jan 17, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·José Carlos Farias Alves FilhoJarbas Rodrigues de Oliveira
Mar 5, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Fernanda B NunesJarbas R de Oliveira
Apr 2, 2005·Shock·Thomas J H VolmanR Jan A Goris
May 24, 2005·Nature Immunology·Paul J Godowski
Dec 6, 2005·Cerebrovascular Diseases·Miguel BlancoJosé Castillo
Sep 16, 2006·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·R Pestana LopesM E Bauer
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sean GarreanAsrar B Malik
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helen S GoodridgeDavid M Underhill
Oct 1, 2008·International Immunopharmacology·Hui YinJia-Yong Zhu
Mar 24, 2009·Annual Review of Immunology·Sivakumar Vallabhapurapu, Michael Karin
Aug 4, 2009·The FEBS Journal·Joan DuranRamon Bartrons
Mar 23, 2010·Respiratory Research·Yun-Feng NiTao Jiang
Aug 24, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kristian-Christos NgamsriJörg Reutershan
Oct 26, 2010·Critical Care : the Official Journal of the Critical Care Forum·Christian MutzPeter Rosenberger
Nov 9, 2010·Critical Care Medicine·Jurjan AmanA B Johan Groeneveld
Nov 26, 2010·Inflammation·Roberto Christ Vianna SantosJarbas Rodrigues de Oliveira
Dec 28, 2010·Clinical Biochemistry·Etiane TatschRafael Noal Moresco
Jun 24, 2011·Cytokine·Richard F OppeltzMartin G Schwacha
Jul 28, 2011·The Journal of Pharmacology and Experimental Therapeutics·T StevensA Sanfridson
Citations
Jul 12, 2018·Inflammation·Renan Trevisan JostJarbas Rodrigues de Oliveira
Nov 10, 2013·PloS One·Carolina Costola-de-SouzaJoão Palermo-Neto
Sep 12, 2019·PloS One·Henrique Bregolin DiasShioko Kimura
May 5, 2016·Oncotarget·Jun-Tang LiLin-Tao Jia
Sep 28, 2017·Clinical and Experimental Pharmacology & Physiology·Demet UnsalSeyhan Sahan-Firat
May 6, 2016·Inflammation·Guilherme Vargas BochiRafael Noal Moresco
Mar 21, 2019·Journal of Natural Products·Ya-Zhen LiWei-Lan Yeh